Geron Corp (GERN)

[Charleston]

Survival numbers of a treatment for a hopeless RR state is key for FDA approval. When all the best solutions modern medicine provides is not enough, the patients desperately needs an answer.

In steps Imetelstat with unprecedented results that include complete remissions. A novel treatment attacks cancer from a new angle. One that solves a problem lacking a solution. Results showing unheard of survival rates thus far, beating expectations by 2-300%. Is this the future for how cancer should be treated? 2 indications may justify testing its mettle against an advanced form of the cancer.

This is a lull before a violent storm in oncology.